Why it matters
CBD’s pharmacokinetic profile is unusual for a consumer compound. Oral bioavailability is low, distribution into adipose tissue is high, metabolism is via CYP3A4 and CYP2C19, and elimination half-life is long. Steady-state plasma levels after chronic dosing take days to a week to establish.
In practice
For consumers the practical takeaways: dosing on an empty stomach delivers less CBD than dosing with fatty food; effect builds across the first week of consistent use; sublingual administration improves bioavailability over swallowed oil.
Common confusion
“CBD only works after weeks of use” is partly right (chronic accumulation effects) and partly wrong (single-dose effects are detectable in minutes for inhaled and within an hour for sublingual).
This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.